Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)

Author(s):  Whaley Paul A, Voudrie Mark A II, Sorenson Bridget

Issue:  Mar/Apr 2012 - Volume 16, Number 2
View All Articles in Issue

Page(s):  164-166

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Page 1
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Page 2
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Page 3

Download in electronic PDF format for $75

Abstract:  Omeprazole is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger–Ellison syndrome. Omeprazole is marketed by AstraZeneca under a number of names, most notably Prilosec and Losec, as well as being available from a number of generic manufacturers. Omeprazole is available in both tablet and capsule form, with varying strengths of each. The need for other administration options for those patients who cannot take tablets or capsules has led compounding pharmacies to seek other alternatives. One possible alternative is the use of a suspending agent to create an oral solution or suspension. In the past, this has been accomplished using a sodium bicarbonate solution as the vehicle. However, sodium bicarbonate/omeprazole combination imparts a bitter and unpleasant taste. SyrSpend SF Alka (reconstituted) is a vehicle for making a suspension which has a pleasant taste, thus increasing palpability and compliance. The objective of this study was to determine the stability of omeprazole in SyrSpend SF Alka (for reconstitution). The studied sample was compounded into a 2-mg/mL suspension and stored in a low-actinic plastic prescription bottle at temperatures between 2oC and 8oC. Six samples were assayed at each time point out to 92 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced degradation studies. The shelf life of this product is at least 92 days, based on data collected when refrigerated and protected from light.

Related Keywords: omeprazole, peptic ulcer disease, gastroesophageal reflux disease, GERD, dyspepsia, suspension, stability

Related Categories: EXCIPIENTS, GASTROENTEROLOGY, PACKAGING, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A
, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2012
Pg. 164-166

Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay
, Williams LaVonn A
Mar/Apr 2011
Pg. 124-128

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 409

The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja
, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020
Pg. 140-147

Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Spennacchio Antonio
, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2023
Pg. 250-255

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Omeprazole 2-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2006
Pg. 389

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Garg Sanjay
, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
May/Jun 2009
Pg. 250-253

Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M
, Sorenson Bridget, Whaley Paul
Sep/Oct 2015
Pg. 420-427

Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013
Pg. 344-346

Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 246

Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B
, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Jul/Aug 2020
Pg. 327-336

Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II
, Allen D Brett
Jan/Feb 2010
Pg. 82-85

Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T
, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Nov/Dec 2008
Pg. 558-564

Stability of Gabapentin in SyrSpend SF
Sorenson Bridget
, Voudrie Mark A II, Gehrig Dan
Jul/Aug 2012
Pg. 347-349

Stability of Propranolol Hydrochloride in SyrSpend SF
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 513-515

Return to Top